SCHEMBL6422572

SCHEMBL6422572

O=C(c1cc(Cl)ccc1Cl)N1CCCCC1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.71
KDM4E B2RXH2 2/20 0.71
LMNA P02545 1/20 0.71
TP53 P04637 1/20 0.71
ALOX15 P16050 1/20 0.71
HPGD P15428 4/20 0.61
HSP90AA1 P07900 2/20 0.57
HSD17B10 Q99714 2/20 0.57
USP2 O75604 1/20 0.57
CNR2 P34972 1/20 0.56
POLB P06746 1/20 0.56
NPC1 O15118 3/20 0.55
RAB9A P51151 2/20 0.55
CASP3 P42574 1/20 0.55
SENP8 Q96LD8 1/20 0.55
SENP7 Q9BQF6 1/20 0.55
SENP6 Q9GZR1 1/20 0.55
MAPT P10636 1/20 0.54
ALPL P05186 2/20 0.53
GLA P06280 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14825161 0.93 TSHR (0.77) TSHRKDM4ELMNATP53ALOX15
SCHEMBL11713011 0.91 LMNA (0.84) TSHRKDM4ELMNATP53ALOX15
SCHEMBL2678029 0.87 TSHR (0.68) TSHRKDM4ELMNATP53ALOX15
SCHEMBL11488934 0.86 MEN1 (0.62) TSHRKDM4ELMNATP53ALOX15
SCHEMBL29944105 0.86 MEN1 (0.62) TSHRKDM4ELMNATP53ALOX15
SCHEMBL487595 0.85 HSP90AA1 (0.64) TSHRKDM4ELMNATP53ALOX15
SCHEMBL24508969 0.84 P2RX7 (0.60) TSHRKDM4ELMNATP53ALOX15
SCHEMBL2740465 0.83 TP53 (0.68) TSHRKDM4ELMNATP53ALOX15
SCHEMBL1042677 0.83 KDM4E (1.00) TSHRKDM4ELMNATP53ALOX15
SCHEMBL22767344 0.83 HPGD (0.58) TSHRKDM4ELMNATP53ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0489085-B1 RIGID-ROD POLYMERS MISSISSIPPI POLYMER TECHNOLOGI (US) 2005-12-07 EP claimed
US-5565543-A Rigid-rod polymers MAXDEM INCORPORATED (US) 1996-10-15 US claimed
EP-0489085-A4 RIGID-ROD POLYMERS MAXDEM INC (US) 1992-08-05 EP claimed
EP-0489085-A1 RIGID-ROD POLYMERS MAXDEM INCORPORATED (US) 1992-06-10 EP claimed
WO-1991002764-A1 RIGID-ROD POLYMERS MAXDEM INCORPORATED (US) 1991-03-07 WO claimed
US-20230110003-A1 PIPERIDINE DERIVATIVES AND COMPOSITIONS FOR THE INHIBITION OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) Valo Health, LLC 2023-04-13 US disclosed
US-11479564-B2 Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (NAMPT) VALO HEALTH, INC. (US) 2022-10-25 US disclosed
EP-0489085-B1 RIGID-ROD POLYMERS MISSISSIPPI POLYMER TECHNOLOGI (US) 2005-12-07 EP disclosed
EP-1352731-A2 Method of orienting polymer molecules MISSISSIPPI POLYMER TECHNOLOGIES, INC. (US) 2003-10-15 EP disclosed
EP-0629217-B1 RIGID-ROD POLYMERS MISSISSIPPI POLYMER TECHNOLOGI (US) 2003-05-07 EP disclosed
EP-0599886-B1 MACROMONOMERS HAVING REACTIVE END GROUPS MISSISSIPPI POLYMER TECH INC (US) 2001-03-21 EP disclosed
EP-0646143-B1 MACROMONOMERS HAVING REACTIVE SIDE GROUPS MAXDEM INC (US) 2000-10-18 EP disclosed
EP-0629217-A1 RIGID-ROD POLYMERS MAXDEM INCORPORATED (US) 1994-12-21 EP disclosed
EP-0599886-A1 MACROMONOMERS HAVING REACTIVE END GROUPS MAXDEM INCORPORATED (US) 1994-06-08 EP disclosed
WO-1993018077-A1 RIGID-ROD POLYMERS MAXDEM INCORPORATED (US) 1993-09-16 WO disclosed
WO-1993018076-A1 RIGID-ROD POLYMERS MAXDEM INCORPORATED (US) 1993-09-16 WO disclosed
WO-1993004099-A1 MACROMONOMERS HAVING REACTIVE END GROUPS MAXDEM INCORPORATED (US) 1993-03-04 WO disclosed
EP-0489085-A4 RIGID-ROD POLYMERS MAXDEM INC (US) 1992-08-05 EP disclosed
EP-0489085-A1 RIGID-ROD POLYMERS MAXDEM INCORPORATED (US) 1992-06-10 EP disclosed
WO-1991002764-A1 RIGID-ROD POLYMERS MAXDEM INCORPORATED (US) 1991-03-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230110003-A1 PIPERIDINE DERIVATIVES AND COMPOSITIONS FOR THE INHIBITION OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) NAMPT, NAPRT, NNMT TSHR 3065/4885KDM4E 2054/4885LMNA 1753/4885
US-11479564-B2 Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (NAMPT) NAMPT, NAPRT, NNMT TSHR 3065/4885KDM4E 2054/4885LMNA 1753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.